Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Biothera collaborates with Merck for combination cancer immunotherapy trials in multiple indications Biothera Pharmaceuticals announced a collaboration with Merck to expand the companies’ ongoing clinical program evaluating KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP.
Contract Research & Services > Contract Research > News
Xycrobe signs research deal with Johnson & Johnson Consumer Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
Contract Research & Services > Contract Research > News Abeona, EBRP and EB MRF to collaborate on epidermolysis bullosa treatments Abeona Therapeutics, EB Research Partnership (EBRP) and EB Research Medical Foundation (EBMRF) announced a collaboration focusing on gene therapy treatments for epidermolysis bullosa (EB), a group of devastating rare genetic skin disorders impacting children; characterized by skin blisters and erosions all over the body.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Almac Group Supports Amicus Therapeutics' Commercial Orphan Drug Product
Almac Group's Integrated Development to Commercialisation Services Support Amicus Therapeutics' First Commercial Orphan Drug Product.
Contract Research & Services > Contract Research > Press Releases
Abeona, EBRP and EB MRF to collaborate on epidermolysis bullosa treatments
Abeona Therapeutics, EB Research Partnership (EBRP) and EB Research Medical Foundation (EBMRF) announced a collaboration focusing on gene therapy treatments for epidermolysis bullosa (EB), a group of devastating rare genetic skin disorders impacting children; characterized by skin blisters and erosions all over the body.
Contract Research & Services > Contract Research > News
Proteostasis completes preclinical milestone in collaboration with Astellas Pharma
Proteostasis Therapeutics has completed a key preclinical milestone in its collaboration with Astellas Pharma.
Contract Research & Services > Contract Research > News
Codexis completes obligations under research and development deal with biopharmaceutical firm
Codexis has completed its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.
Contract Research & Services > Contract Research > News
Pfizer, Western Oncolytics establish immuno-oncology research collaboration
Pfizer and Western Oncolytics have entered into a development collaboration, license and option agreement to advance Western Oncolytics’ novel oncolytic vaccinia virus, WO-12.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, Janssen collaborate on lung cancer treatment
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and Janssen Biotech have signed a clinical study collaboration agreement to evaluate the combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC).
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests